- Home
- ACHV vs FMN Comparison
ACHV vs FMN Comparison
Compare ACHV & FMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- FMN
- Stock Information
- Founded
- ACHV N/A
- FMN 2002
- Country
- ACHV Canada
- FMN United States
- Employees
- ACHV N/A
- FMN N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- FMN Investment Managers
- Sector
- ACHV Health Care
- FMN Finance
- Exchange
- ACHV Nasdaq
- FMN Nasdaq
- Market Cap
- ACHV 72.5M
- FMN 82.6M
- IPO Year
- ACHV N/A
- FMN N/A
- Fundamental
- Price
- ACHV $3.35
- FMN $10.61
- Analyst Decision
- ACHV Strong Buy
- FMN
- Analyst Count
- ACHV 3
- FMN 0
- Target Price
- ACHV $14.33
- FMN N/A
- AVG Volume (30 Days)
- ACHV 325.9K
- FMN 22.8K
- Earning Date
- ACHV 08-12-2025
- FMN 01-01-0001
- Dividend Yield
- ACHV N/A
- FMN 3.86%
- EPS Growth
- ACHV N/A
- FMN N/A
- EPS
- ACHV N/A
- FMN N/A
- Revenue
- ACHV N/A
- FMN N/A
- Revenue This Year
- ACHV N/A
- FMN N/A
- Revenue Next Year
- ACHV N/A
- FMN N/A
- P/E Ratio
- ACHV N/A
- FMN N/A
- Revenue Growth
- ACHV N/A
- FMN N/A
- 52 Week Low
- ACHV $1.84
- FMN $9.09
- 52 Week High
- ACHV $5.31
- FMN $11.31
- Technical
- Relative Strength Index (RSI)
- ACHV 52.46
- FMN 47.31
- Support Level
- ACHV $3.44
- FMN $10.52
- Resistance Level
- ACHV $3.91
- FMN $10.72
- Average True Range (ATR)
- ACHV 0.30
- FMN 0.07
- MACD
- ACHV -0.09
- FMN 0.00
- Stochastic Oscillator
- ACHV 28.03
- FMN 33.33
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About FMN Federated Hermes Premier Municipal Income Fund
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.